Graham Jang

2.7k total citations · 1 hit paper
26 papers, 1.5k citations indexed

About

Graham Jang is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Graham Jang has authored 26 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in Graham Jang's work include Bone health and treatments (7 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Estrogen and related hormone effects (4 papers). Graham Jang is often cited by papers focused on Bone health and treatments (7 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Estrogen and related hormone effects (4 papers). Graham Jang collaborates with scholars based in United States, Germany and United Kingdom. Graham Jang's co-authors include Desmond Padhi, Brian Stouch, Edward L. Posvar, Liang Fang, Robert Z. Harris, Shirley M. Tsunoda, Leslie Z. Benet, Sameer Doshi, Juan José Pérez Ruixo and Andrew Chow and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of Bone and Mineral Research.

In The Last Decade

Graham Jang

26 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody

2010 603 citations Desmond Padhi, Graham Jang et al. Journal of Bone and Mineral Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Graham Jang United States	16	724	724	533	147	146	26	1.5k
Douglas B. Muchmore United States	22	407 0.6×	460 0.6×	296 0.6×	19 0.1×	48 0.3×	56	1.9k
Lyne Gagnon Canada	19	565 0.8×	317 0.4×	55 0.1×	24 0.2×	30 0.2×	52	1.2k
Hiroshi Kusama Japan	21	349 0.5×	240 0.3×	58 0.1×	46 0.3×	33 0.2×	74	1.1k
Olivier Grenet Switzerland	15	550 0.8×	223 0.3×	29 0.1×	80 0.5×	29 0.2×	27	1.1k
Hakan Çamlıca Türkiye	22	510 0.7×	526 0.7×	31 0.1×	19 0.1×	63 0.4×	68	1.5k
Poonkuzhali Balasubramanian India	26	1.2k 1.7×	553 0.8×	52 0.1×	118 0.8×	17 0.1×	137	2.4k
Joseph E. Baggott United States	25	480 0.7×	168 0.2×	35 0.1×	58 0.4×	33 0.2×	67	1.9k
Xiaobo He China	21	546 0.8×	943 1.3×	41 0.1×	39 0.3×	50 0.3×	69	1.8k
Stephen J. Iturria United States	15	276 0.4×	179 0.2×	31 0.1×	73 0.5×	28 0.2×	23	1.2k
Nina H. Bjarnason Denmark	11	619 0.9×	785 1.1×	868 1.6×	22 0.1×	26 0.2×	18	2.2k

Countries citing papers authored by Graham Jang

Since Specialization

Citations

This map shows the geographic impact of Graham Jang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graham Jang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graham Jang more than expected).

Fields of papers citing papers by Graham Jang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graham Jang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graham Jang. The network helps show where Graham Jang may publish in the future.

Co-authorship network of co-authors of Graham Jang

This figure shows the co-authorship network connecting the top 25 collaborators of Graham Jang. A scholar is included among the top collaborators of Graham Jang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graham Jang. Graham Jang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jang, Graham, et al.. (2014). A clinical therapeutic protein drug–drug interaction study: coadministration of denosumab and midazolam in postmenopausal women with osteoporosis. Pharmacology Research & Perspectives. 2(2). e00033–e00033. 12 indexed citations

Sohn, Winnie, et al.. (2014). The pharmacokinetics and pharmacodynamics of denosumab in patients with advanced solid tumours and bone metastases: a systematic review. British Journal of Clinical Pharmacology. 78(3). 477–487. 43 indexed citations

Gibiansky, Leonid, Liviawati Sutjandra, Sameer Doshi, et al.. (2012). Population Pharmacokinetic Analysis of Denosumab in Patients with Bone Metastases from Solid Tumours. Clinical Pharmacokinetics. 51(4). 247–260. 69 indexed citations

Allison, Mark, et al.. (2012). Effects of multiple doses of the sclerostin antibody AMG 785 in healthy men and postmenopausal women with low bone mass. Bone. 50. S34–S35. 1 indexed citations

Doshi, Sameer, Liviawati Sutjandra, Jenny Zheng, et al.. (2012). Denosumab Dose Selection for Patients with Bone Metastases from Solid Tumors. Clinical Cancer Research. 18(9). 2648–2657. 26 indexed citations

Sutjandra, Liviawati, Sameer Doshi, Mark Ma, et al.. (2011). Population Pharmacokinetic Meta-Analysis of Denosumab in Healthy Subjects and Postmenopausal Women with Osteopenia or Osteoporosis. Clinical Pharmacokinetics. 50(12). 793–807. 87 indexed citations

Padhi, Desmond, Graham Jang, Brian Stouch, Liang Fang, & Edward L. Posvar. (2010). Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody. Journal of Bone and Mineral Research. 26(1). 19–26. 603 indexed citations breakdown →

Agoram, Balaji, Ken Aoki, Sameer Doshi, et al.. (2008). Investigation of the effects of altered receptor binding activity on the clearance of erythropoiesis-stimulating proteins: Nonerythropoietin receptor-mediated pathways may play a major role. Journal of Pharmaceutical Sciences. 98(6). 2198–2211. 26 indexed citations

Macdougall, Iain C., et al.. (2007). Pharmacology of darbepoetin alfa. Nephrology Dialysis Transplantation. 22(Supplement 4). iv2–iv9. 31 indexed citations

10.

Jang, Graham & Robert Z. Harris. (2007). Drug interactions involving ethanol and alcoholic beverages. Expert Opinion on Drug Metabolism & Toxicology. 3(5). 719–731. 32 indexed citations

11.

Jang, Graham & Robert Z. Harris. (2007). Drug interactions involving ethanol and alcoholic beverages. Expert Opinion on Drug Metabolism & Toxicology. 3(5). 719–731. 5 indexed citations

12.

Padhi, Desmond, Liyun Ni, Blaire Cooke, Rafael Marino, & Graham Jang. (2006). An Extended Terminal Half-Life for Darbepoetin Alfa. Clinical Pharmacokinetics. 45(5). 503–510. 31 indexed citations

13.

Peterson, M., et al.. (2006). Selection of a phase 3 dose regimen for denosumab based on pharmacokinetic (PK), pharmacodynamic (PD), and safety data from multiple subcutaneous (SC) dosing regimens in breast cancer patients (pts) with bone metastases (BM). Journal of Clinical Oncology. 24(18_suppl). 3086–3086. 11 indexed citations

14.

Tamayo, Nuria, David Powers, Yanyan Tudor, et al.. (2005). Design and synthesis of potent pyridazine inhibitors of p38 MAP kinase. Bioorganic & Medicinal Chemistry Letters. 15(9). 2409–2413. 40 indexed citations

15.

Rose, William C., Punit H. Marathe, Graham Jang, et al.. (2005). Novel fluoro-substituted camptothecins: in vivo antitumor activity, reduced gastrointestinal toxicity and pharmacokinetic characterization. Cancer Chemotherapy and Pharmacology. 58(1). 73–85. 12 indexed citations

16.

Harris, Robert Z., Graham Jang, & Shirley M. Tsunoda. (2003). Dietary Effects on Drug Metabolism and Transport. Clinical Pharmacokinetics. 42(13). 1071–1088. 153 indexed citations

17.

Jang, Graham, Robert Z. Harris, & David T. W. Lau. (2001). Pharmacokinetics and its role in small molecule drug discovery research. Medicinal Research Reviews. 21(5). 382–396. 64 indexed citations

18.

Jang, Graham & Leslie Z. Benet. (1998). Antiprogestin-Mediated Inactivation of Cytochrome P450 3A4. Pharmacology. 56(3). 150–157. 11 indexed citations

19.

Jang, Graham & Leslie Z. Benet. (1997). Antiprogestin Pharmacodynamics, Pharmacokinetics, and Metabolism: Implications for Their Long-Term Use. Journal of Pharmacokinetics and Biopharmaceutics. 25(6). 647–672. 13 indexed citations

20.

Jang, Graham, Steven Wrighton, & Leslie Z. Benet. (1996). Identification of CYP3A4 as the principal enzyme catalyzing mifepristone (RU 486) oxidation in human liver microsomes. Biochemical Pharmacology. 52(5). 753–761. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact